NCT06444477 2026-01-26
MATAC
University Hospital, Bordeaux
Completed
Clinical Trials
5 trialsNCT06873672 2025-03-13
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
RenJi Hospital
Not yet recruiting
NCT05393999 2023-04-24
SABRE
Imperial College Healthcare NHS Trust
Phase 2 Withdrawn
NCT05328804 2022-04-26
Herombopag + rhTPO in Severe Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT01610180 2018-07-16
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
Fondazione Progetto Ematologia
Phase 2 Completed